APA

Zelniker T. A., Wiviott S. D., Raz I., Im K., Goodrich E. L., Furtado R. H. M., Bonaca M. P., Mosenzon O., Kato E. T., Cahn A., Bhatt D. L., Leiter L. A., McGuire D. K., Wilding J. P. H. & Sabatine M. S. (20200214). Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus. : Circulation.

Chicago

Zelniker Thomas A, Wiviott Stephen D, Raz Itamar, Im KyungAh, Goodrich Erica L, Furtado Remo H M, Bonaca Marc P, Mosenzon Ofri, Kato Eri T, Cahn Avivit, Bhatt Deepak L, Leiter Lawrence A, McGuire Darren K, Wilding John P H and Sabatine Marc S. 20200214. Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus. : Circulation.

Harvard

Zelniker T. A., Wiviott S. D., Raz I., Im K., Goodrich E. L., Furtado R. H. M., Bonaca M. P., Mosenzon O., Kato E. T., Cahn A., Bhatt D. L., Leiter L. A., McGuire D. K., Wilding J. P. H. and Sabatine M. S. (20200214). Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus. : Circulation.

MLA

Zelniker Thomas A, Wiviott Stephen D, Raz Itamar, Im KyungAh, Goodrich Erica L, Furtado Remo H M, Bonaca Marc P, Mosenzon Ofri, Kato Eri T, Cahn Avivit, Bhatt Deepak L, Leiter Lawrence A, McGuire Darren K, Wilding John P H and Sabatine Marc S. Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus. : Circulation. 20200214.